Will AstraZeneca slow down the UK's reopening?
Apr 07, 2021•11 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Under-30s should be offered an alternative to the Oxford/AstraZeneca jab, the UK's vaccine regulator said this afternoon. What does this mean for the UK's roadmap? Katy Balls speaks to James Forsyth and Kate Andrews.
Become a Spectator subscriber today to access this podcast without adverts. Go to spectator.co.uk/adfree to find out more.
For more Spectator podcasts, go to spectator.co.uk/podcasts.
Contact us: podcast@spectator.co.uk
Hosted on Acast. See acast.com/privacy for more information.
For the best experience, listen in Metacast app for iOS or Android